Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Intermediate-Dose Cyclophosphamide Versus Plerixafor and Granulocyte Colony Stimulating Factor (G-CSF) for Peripheral Blood Progenitor Cell (PBPC) Mobilization in Patients with Multiple Myeloma (MM) Treated with Novel Induction Chemotherapies – A Multicenter Analysis

Farrukh Awan, MD, MS, Samith Thomas Kochuparambil, Michael Craig, Aaron Cumpston, PharmD, Sonia Leadmon, BS, Kathy Watkins, David Deremer, Jeremy Pantin, MD, Vamsi Kota, MBBS, Anand P. Jillella, MD, Mehdi Hamadani, MD

Blood (2012) 120 (21): 4409.

https://doi.org/10.1182/blood.V120.21.4409.4409

Published: 2012

Journal Articles

Defining Treatment Paradigms for BK Virus-Induced Hemorrhagic Cystitis in the Post-Allogeneic Hematopoietic Stem Cell Transplant Setting

Devi D Morrison, Samith Thomas Kochuparambil, David Deremer, Ethan Speir, Kristen Sterling, Meghan Sterrett, Vamsi Kota, MBBS, Anand P. Jillella, MD, Farrukh T Awan, MD, MS

Blood (2011) 118 (21): 4468.

https://doi.org/10.1182/blood.V118.21.4468.4468

Published: 2011

Journal Articles

Allogeneic Transplantation Following Reduced Intensity Conditioning with Fludarabine and Melphalan In Patients with Advanced Myelofibrosis Is Associated with Unacceptable Rates of Acute Graft-Vs-Host Disease and Non-Relapse Mortality.

Samith Thomas Kochuparambil, Kavita Natrajan, Anand P. Jillella, MD, Sayed Mehdi Hamadani, MD, Farrukh Awan, MD, MS

Blood (2010) 116 (21): 4552.

https://doi.org/10.1182/blood.V116.21.4552.4552

Published: 2010

Journal Articles

Utility of Plerixafor In Addition to Chemotherapy and G-CSF Mobilization Regimens

Farrukh Awan, MD, MS, David Deremer, Elaine Mebel, Samith Thomas Kochuparambil, Anand P. Jillella, MD

Blood (2010) 116 (21): 4443.

https://doi.org/10.1182/blood.V116.21.4443.4443

Published: 2010

Journal Articles

Impact of Response to Thalidomide, Lenalidomide or Bortezomib Containing Induction Chemotherapy on Outcomes of Multiple Myeloma Patients Undergoing Autologous Transplantation – A Multicenter Analysis

Farrukh Awan, MD, MS, Salman Osman, MD, Samith Thomas Kochuparambil, Scot Remick, MD, FACP, Jame Abraham, MD, FACP, Michael Craig, MD, Anand P. Jillella, MD, Sayed Mehdi Hamadani, MD

Blood (2010) 116 (21): 1351.

https://doi.org/10.1182/blood.V116.21.1351.1351

Published: 2010

NARROW

Intermediate-Dose Cyclophosphamide Versus Plerixafor and Granulocyte Colony Stimulating Factor (G-CSF) for Peripheral Blood Progenitor Cell (PBPC) Mobilization in Patients with Multiple Myeloma (MM) Treated with Novel Induction Chemotherapies – A Multicenter Analysis

Defining Treatment Paradigms for BK Virus-Induced Hemorrhagic Cystitis in the Post-Allogeneic Hematopoietic Stem Cell Transplant Setting

Allogeneic Transplantation Following Reduced Intensity Conditioning with Fludarabine and Melphalan In Patients with Advanced Myelofibrosis Is Associated with Unacceptable Rates of Acute Graft-Vs-Host Disease and Non-Relapse Mortality.

Utility of Plerixafor In Addition to Chemotherapy and G-CSF Mobilization Regimens

Impact of Response to Thalidomide, Lenalidomide or Bortezomib Containing Induction Chemotherapy on Outcomes of Multiple Myeloma Patients Undergoing Autologous Transplantation – A Multicenter Analysis

Email alerts

ASH Publications

American Society of Hematology

Intermediate-Dose Cyclophosphamide Versus Plerixafor and Granulocyte Colony Stimulating Factor (G-CSF) for Peripheral Blood Progenitor Cell (PBPC) Mobilization in Patients with Multiple Myeloma (MM) Treated with Novel Induction Chemotherapies – A Multicenter Analysis

Defining Treatment Paradigms for BK Virus-Induced Hemorrhagic Cystitis in the Post-Allogeneic Hematopoietic Stem Cell Transplant Setting

Allogeneic Transplantation Following Reduced Intensity Conditioning with Fludarabine and Melphalan In Patients with Advanced Myelofibrosis Is Associated with Unacceptable Rates of Acute Graft-Vs-Host Disease and Non-Relapse Mortality.

Utility of Plerixafor In Addition to Chemotherapy and G-CSF Mobilization Regimens

Impact of Response to Thalidomide, Lenalidomide or Bortezomib Containing Induction Chemotherapy on Outcomes of Multiple Myeloma Patients Undergoing Autologous Transplantation – A Multicenter Analysis

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only